Opioid Use
529
68
87
296
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
113 trials with published results (21%)
Research Maturity
296 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.8%
41 terminated out of 529 trials
87.8%
+1.2% vs benchmark
21%
112 trials in Phase 3/4
38%
113 of 296 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 296 completed trials
Clinical Trials (529)
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
SPSIP Block Versus ESP Block for Chronic Pain After Unilateral Breast Surgery
Serratus vs ESP Block for Postoperative Pain in Unilateral Breast Surgery
rTMS as Add on Treatment for Substance Use Disorders
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use
Efficacy of Erector Spinae Plane (ESP) Block in Patients With Inflammatory Bowel Disease (IBD)
A Prospective Randomized Double Blind Trial to Assess the Effect of a Single Preoperative Dose of Gabapentin on Postoperative Opioid Consumption in Patients Undergoing Rhinoplasty
Affective Effects of Pre-surgery Opioids: a Randomized, Doubleblind Placebo-controlled Trial
Healing After Injury to Reduce Opioid Use and Pain Through Preventive Engagement - Open Trial
Enhancing Prospective Thinking in Early Recovery (PARK)
Effects of Erector Spinae Plane Block and Paravertebral Block on Early Postoperative Pulmonary Function Test Parameters
Personalized Feedback Intervention for Alcohol and Opioid Use Among Adults With Chronic Pain
PRIDE III Prison Interventions and HIV Prevention Collaboration
Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section
Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty
Opioid Analgesic Reduction Study
Mindfulness for Pain and Suicide
Prevention Interventions for Opioid Misuse
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion